Palantir stock has gone from expensive to extremely expensive. Its trailing price-to-earnings ratio of 574 and forward earnings multiple of 238 are far from value territory. By comparison, the ...

Bio-Techne appears overvalued despite strong revenue growth, solid debt coverage, and looming U.S. healthcare funding cuts.

The Vanguard Information Technology ETF tracks the MSCI US Investable Market Information Technology 25/50 index, which includes more than 300 technology companies. That's great for tech investors ...